Can an Artificial Kidney Finally Free Patients from Dialysis?
Scientist proved for the first time that kidney cells, housed in an implantable device functioning as an artificial kidney, can survive inside the body of an animal.

University of California San Francisco
Give to UCSFScientist proved for the first time that kidney cells, housed in an implantable device functioning as an artificial kidney, can survive inside the body of an animal.
A brain implant and digital avatar allow a paralyzed stroke survivor to speak with for first time in 18 years with the help of artificial intelligence.
A new digital headset designed to measure alterations in brain function could change decisions about how quickly an athlete is ready to return to play after a concussion.
Drawing on her decades of research and clinical experience, Mahtab Jafari, PharmD ’94, a professor of pharmaceutical sciences at UC Irvine, sheds light on the largely unregulated supplement industry and empowers readers to make choices informed by science.
UCSF’s Nevan Krogan, PhD, is taking aim at the world’s deadliest diseases by uniting scientists and the biomedical industry to speed treatments.
In a breakthrough, “HT” became the first person in the world to receive gene-corrected stem cells for Artemis-SCID.
Tippi MacKenzie is leading grounbreaking clinical trials of therapies aimed at stopping fetuses from developing devastating disorders.
The advent of cheap, easy-to-use blood tests for Alzheimer’s disease has the potential to revolutionize diagnosis and treatment. But they also raise difficult questions that the field is only beginning to consider.
Engineered immune cells. Supercharged scans. Drug implants. Gene manipulators. Blood biopsies. Read how these breakthroughs are transforming cancer care.
A new treatment approach draws on research into the unique teenage brain.
Thermo Fisher Scientific Inc. and UCSF will accelerate advanced cell therapies for difficult to treat conditions like cancer from a new manufacturing facility.
A new AI language program developed by Salesforce can learn the language of biology to create artificial proteins.
People trying to conceive are bombarded with advice meant to improve their odds. But how much power do we really have over our fertility?
Trillions of invisible organisms make up the human microbiome. Now, medical scientists want to put these bugs to work.
On the operating table and inside the lab of a rising star in cancer neurosurgery.
Could psychedelics become mainstream medicines?
The Opioid Industry Documents Archive (OIDA), a project of UCSF, and Johns Hopkins University, today released more than 114,000 documents related to McKinsey & Company's work as a management consulting firm for the opioid industry.
Glimpse the technologies that will catapult neurosurgery to the next level of precision.
UCSF sports medicine experts share their savvy on how to overcome injuries and stay active for life.
What happens once abortion is illegal in half the country?
How David Julius and Ardem Patapoutian found the molecules in our bodies that sense heat, cold, touch, and pain – and transformed sensory neuroscience.
A significant proportion of bacterial sexually transmitted infections – gonorrhea, chlamydia, or syphilis – were prevented with a dose of doxycycline after unprotected sex, according to preliminary results of a clinical trial.
Scientists at UCSF QBI and the QBI Coronavirus Research Group (QCRG) have been awarded $67.5 million from the National Institute of Allergy and Infectious Diseases (NIAID) to support its mission of pandemic preparedness.
For 29 years, Rashetta Higgins was wracked by epileptic seizures. UCSF neurologists used a pioneering imaging technique to spot what was triggering them and then removed that region from her brain. Now Rashetta is living a seizure-free life.
Using AI in ECG analysis improves diagnosis, treatment and monitoring of hypertrophic cardiomyopathy, a leading cause of sudden death in adolescents.
A natural language processing study parses doctor-patient communication at an unprecedented scale and offers new ways to help doctors communicate with their patients.
UCSF neurologist Gil Rabinovici, MD, explains the controversy and shares why he thinks Alzheimer’s care is entering a new era “regardless of whether aducanumab proves to be a blockbuster or a bust.”